Get the latest tech news
Dexcom starts selling its new over-the-counter glucose monitor in the U.S.
The San Diego company launched the first FDA-approved continuous glucose monitor that doesn’t require a prescription.
San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. Stelo connects to a smartphone application as it constantly measures, records and analyzes the user’s glucose levels and then presents those results in the app every 15 minutes. When Dexcom announced the rollout of Stelo earlier this summer, industry analysts noted the opportunity to tap a growing market of users beyond diabetes patients.
Or read this on Hacker News
